Bile Acids, Total, Pregnancy, Enzymatic
BILEA
Test Summary
Used to screen pregnant women for obstetric cholestasis. Symptoms of cholestasis included persistent itching in the third trimester of pregnancy and possible risks of unborn baby including stillbirth, premature labor and bleeding. The frequency of obstetric cholestasis varies and is 1 in 100 in pregnant European women vs. 1 in 10 in South American women. Total bile acids levels are the most sensitive indicator for monitoring the effectiveness of interferon treatment of chronic hepatitis C patients. Total bile acids are metabolized in the liver and, hence, serve as a marker for normal liver function. Serum total bile acids are increased in patients with acute hepatitis, chronic hepatitis, liver sclerosis and liver cancer.
Aliases
- N/A
Specimen Collection
Special Instructions
Preferred Specimen
Minimum Volume
0.5 mL
Instructions
Patient Preparation
Storage
Transport Temperature
Specimen Stability
- Room temperature: Unacceptable
- Refrigerated: 7 days
- Frozen: 30 days
Limitations
Other Acceptable Specimens
Unacceptable Specimens
Order Code
BILEA
EPIC (Premier) Code
Includes
CPT Code
- 82239
Billing Code
- 670587
CPT Statement
Methodology
FDA Status
Physician Attestation of Informed Consent
Testing Laboratory
14225 Newbrook Drive
Chantilly VA, 20153
Department
Reference Range
Setup Schedule / Expected Turnaround Time
Specimen Collection
Special Instructions
Preferred Specimen
Minimum Volume
0.5 mL
Instructions
Patient Preparation
Storage
Transport Temperature
Specimen Stability
- Room temperature: Unacceptable
- Refrigerated: 7 days
- Frozen: 30 days